Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity.

Authors
Rosenman-KD; Rossman-M; Hertzberg-V; Reilly-MJ; Rice-C; Kanterakis-E; Monos-D
Source
Occup Environ Med 2011 Jul; 68(7):487-493
NIOSHTIC No.
20038465
Abstract
Objectives: Chronic beryllium disease (CBD) is a hypersensitivity granulomatous pulmonary disease caused by exposure to the metal beryllium (Be2+). Our objective was to extend current knowledge of the genetics of beryllium disease by examining all HLA-DPB1 and HLA-DPR1 gene polymorphisms and the interactions between them. Methods: DNA-based typing of HLA-DPB1 and HLA-DRB1 loci at the allele level was performed on 65 CBD, 44 beryllium sensitised (BeS) but without CBD and 288 non-affected, beryllium exposed controls. Results: The DPE69 residue regardless of zygosity, but particularly if present on non-*0201 alleles, was of primary importance for the development of CBD and BeS, while other negatively charged residues DPDE55, 56 and DPDE84, 85 incrementally increased, although not independently, the risk. The DPE69 positive alleles with charge -7 or -9 were associated with both CBD and BeS. The polymorphic residues DPE69, DPDE55, 56 and DPDE84, 85 were responsible for the -9 charge and the first two residues for the -7 charge. Conclusions: In the absence of DPE69, DRE71 is a risk factor for CBD and BeS. DPE69 and DRE71 are adjacent to other amino acids that are also negatively charged, suggesting that the positively charged Be2+ modifies the local environment of the epitopes in a way that promotes interactions between peptides and T cells and results in CBD. Finally, the protective effect of the DPB1*0201 positive haplotype may involve particular polymorphisms outside of the DPB1 gene.
Keywords
Biomarkers; Metal-compounds; Metal-fumes; Genes; Genotoxicity; Genetics; Beryllium-disease; Beryllium-compounds; Lung-disorders; Respiratory-system-disorders; Risk-factors; Surveillance-programs; Epidemiology
Contact
K D Rosenman, Michigan State University, 117 West Fee Hall, East Lansing, MI 48824, USA
CODEN
OEMEEM
CAS No.
7440-41-7
Publication Date
20110701
Document Type
Journal Article
Email Address
rosenman@msu.edu
Funding Type
Grant
Fiscal Year
2011
NTIS Accession No.
NTIS Price
Identifying No.
Grant-Number-R01-OH-007495
Issue of Publication
7
ISSN
1351-0711
Source Name
Occupational and Environmental Medicine
State
GA; PA; MI; OH
Performing Organization
Michigan State University
TOP